跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Magnesium lithospermate B
首页
药物
Magnesium lithospermate B
Magnesium lithospermate B
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Na+/K+-ATP enzyme inhibitor and use thereof
CN 101084887 A
申请人: JIESHENG INTERNAT TECHNOLOGY C
优先权: 2006
CN
Method for Inhibiting Cellular Na+-K+ ATPase Activity
US 2007293462 A1
申请人: JASON LIFE TECH INC LTD
优先权: 2006
US
US 2007293459 A1
申请人: JASON LIFE TECH INC LTD
优先权: 2006
US
METHOD FOR ISOLATION OF HIGH CONCENTRATION OF MAGNESIUM LITHOSPERMATE B FROM SALVIAE MILTIORRHIZAE
US 2010174097 A1
申请人: JUNG MAN KIL
优先权: 2007
US
Application of salvianolate in preparation of kidney protective agent drugs
CN 103417526 A
申请人: SHANGHAI GREENVALLEY PHARMACEUTICAL CO LTD
优先权: 2012
CN
High-purity magnesium lithospermate B and preparation method therefor
US 10259798 B2
申请人: SHANGHAI INST MATERIA MEDICA CAS
优先权: 2014
US
Protective effect and application of magnesium lithospermate B or pharmaceutical composition containing lithospermate B on hepatic ischemia reperfusion
CN 111686103 A
申请人: SHANGHAI INST MATERIA MEDICA CAS
优先权: 2019
CN
药物
反馈